GEMCITABINE\GEMCITABINE for Non-small cell lung cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 314 adverse event reports in the FDA FAERS database where GEMCITABINE\GEMCITABINE was used for Non-small cell lung cancer.
Most Reported Side Effects for GEMCITABINE\GEMCITABINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Disease progression | 951 | 9.3% | 310 | 84 |
| Thrombocytopenia | 939 | 9.2% | 177 | 299 |
| Neutropenia | 907 | 8.9% | 166 | 239 |
| Anaemia | 721 | 7.1% | 149 | 299 |
| Nausea | 603 | 5.9% | 81 | 303 |
| Malignant neoplasm progression | 551 | 5.4% | 157 | 104 |
| Off label use | 542 | 5.3% | 78 | 209 |
| Death | 511 | 5.0% | 511 | 72 |
| Vomiting | 499 | 4.9% | 71 | 268 |
| Pyrexia | 498 | 4.9% | 70 | 348 |
| Diarrhoea | 452 | 4.4% | 74 | 208 |
| Fatigue | 434 | 4.3% | 81 | 169 |
| Drug ineffective | 397 | 3.9% | 102 | 57 |
| Febrile neutropenia | 369 | 3.6% | 102 | 191 |
| Leukopenia | 333 | 3.3% | 43 | 76 |
Other Indications for GEMCITABINE\GEMCITABINE
Pancreatic carcinoma (1,434)
Pancreatic carcinoma metastatic (1,171)
Adenocarcinoma pancreas (693)
Product used for unknown indication (485)
Cholangiocarcinoma (292)
Ovarian cancer (256)
Transitional cell carcinoma (255)
Bladder cancer (240)
Breast cancer metastatic (229)
Diffuse large b-cell lymphoma (209)
Other Drugs Used for Non-small cell lung cancer
NIVOLUMAB (9,987)
CARBOPLATIN (7,939)
PEMBROLIZUMAB (6,893)
OSIMERTINIB (6,358)
PEMETREXED (5,179)
PACLITAXEL (4,609)
ATEZOLIZUMAB (4,459)
BEVACIZUMAB (4,136)
DURVALUMAB (3,396)
ERLOTINIB (3,359)